| Literature DB >> 28730556 |
A Bennis1,2, J G Jacobs3, L A E Catsburg1, J B Ten Brink1,2, C Koster1, R O Schlingemann4,5,6, J van Meurs7, T G M F Gorgels2,8, P D Moerland9, V M Heine10,11, A A Bergen12,13,14.
Abstract
In age-related macular degeneration (AMD) the retinal pigment epithelium (RPE) deteriorates, leading to photoreceptor decay and severe vision loss. New therapeutic strategies aim at RPE replacement by transplantation of pluripotent stem cell (PSC)-derived RPE. Several protocols to generate RPE have been developed where appearance of pigmentation is commonly used as indicator of RPE differentiation and maturation. It is, however, unclear how different pigmentation stages reflect developmental stages and functionality of PSC-derived RPE cells. We generated human embryonic stem cell-derived RPE (hESC-RPE) cells and investigated their gene expression profiles at early pigmentation (EP) and late pigmentation (LP) stages. In addition, we compared the hESC-RPE samples with human endogenous RPE. We used a common reference design microarray (44 K). Our analysis showed that maturing hESC-RPE, upon acquiring pigmentation, expresses markers specific for human RPE. Interestingly, our analysis revealed that EP and LP hESC-RPE do not differ much in gene expression. Our data further showed that pigmented hESC-RPE has a significant lower expression than human endogenous RPE in the visual cycle and oxidative stress pathways. In contrast, we observed a significantly higher expression of pathways related to the process adhesion-to-polarity model that is typical of developing epithelial cells. We conclude that, in vitro, the first appearance of pigmentation hallmarks differentiated RPE. However, further increase in pigmentation does not result in much significant gene expression changes and does not add important RPE functionalities. Consequently, our results suggest that the time span for obtaining differentiated hESC-RPE cells, that are suitable for transplantation, may be greatly reduced.Entities:
Keywords: Age related macular degeneration; Cell replacement therapy; Human embryonic stem cells; Pigmentation; Retinal pigment epithelium; Transcriptomics
Mesh:
Substances:
Year: 2017 PMID: 28730556 PMCID: PMC5602068 DOI: 10.1007/s12015-017-9754-0
Source DB: PubMed Journal: Stem Cell Rev Rep ISSN: 2629-3277 Impact factor: 5.739
Fig. 1(a) Overview of the hESC-RPE differentiation protocol adapted from Zhu et al. [14]. (b) Scheme shows the different time points for collection of samples for validation of hESC-RPE generation (1 = 3 days, 2 = 10–12 days, 3 = 20–25 days, 4 = 30–35 days, 5 = 40–45 days, 6 = 50–55 days, 7 = 60–63 days, 8 = 70 days), by RT-PCR analysis. We also collected RNA when the cells started to show pigmentation (EP) and when more than 80% of the confluent culture was pigmented (LP). (c) RT-PCR analysis at time points 1–8 showed absence and expression of characteristic RPE genes. (d) The hESC-RPE cells started to show first pigmentation phenotypes and typical epithelial hexagonal morphology at timepoint 4
Fig. 2RPE generation was confirmed by immunocytochemistry for the tight junction protein ZO-1, transcription factor MITF, visual cycle related protein RLBP1 and the chloride channel BEST1 (scalebar = 10uM)
Fig. 3Canonical pathways identified by IPA for the genes that are significantly differentially expressed genes between EP and LP samples. The left y-axis displays the –log of the Benjamini-Hochberg corrected –value. The right axis displays the ratio of the number of genes derived from our dataset, divided by the total number of genes in the pathway. The bar graph represents the –log(B-H) p-value. The orange line indicates the threshold at a B-H corrected p-value <0.05
Fig. 4Multidimensional scaling plot to visually represent the (dis)similarities among the different hESC-RPE cell samples. The light blue dots represent the individual EP samples and the dark blue dots represent the LP samples. We used the LIMMA package in R, which is specific for the analysis of microarray data, and included all the normalized expression data of the individual samples: 43,376 entries per sample
Fig. 5Multidimensional scaling plot to visually represent the (dis)similarities among the different hESC-RPE cells (blue dots) and human endogenous RPE (green dots). Also see Fig. 3
Fig. 6Canonical pathways identified by IPA for the genes that are significantly differentially expressed between the hESC-RPE cells and the human endogenous RPE. The left graph (blue) depicts the canonical pathways that relate to the genes specifically expressed in the hESC-RPE (this study). The right graph (green) depicts the canonical pathways that relate to the genes specifically expressed in the human endogenous RPE (submitted). In the graphs, the left y-axis displays the –log of the Benjamini-Hochberg corrected –value. The right axis displays the ratio of the number of genes derived from our dataset, divided by the total number of genes in the pathway. The bars show the –log(B-H) p-value. The orange line indicates the threshold at a B-H corrected p-value <0.05